Detalhe da pesquisa
1.
Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study.
Br J Cancer
; 108(12): 2565-72, 2013 Jun 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-23722472
2.
Randomized phase II study of fulvestrant plus palbociclib or placebo in endocrine-sensitive, hormone receptor-positive/HER2-advanced breast cancer: GEICAM/2014-12 (FLIPPER).
Eur J Cancer
; 161: 26-37, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34902765
3.
Non-pegylated liposomal doxorubicin combined with gemcitabine as first-line treatment for metastatic or locally advanced breast cancer. Final results of a phase I/II trial.
Breast Cancer Res Treat
; 116(2): 351-8, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18941891
4.
Recommendations by the Spanish Society of Hospital Pharmacy, the Spanish Society of Oncology Nursing and the Spanish Society of Medical Oncology for the safe management of antineoplastic medication in cancer patients.
Clin Transl Oncol
; 21(4): 467-478, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30298467
5.
SEOM clinical guidelines on nutrition in cancer patients (2018).
Clin Transl Oncol
; 21(1): 87-93, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30617923
6.
SEOM clinical guidelines on cardiovascular toxicity (2018).
Clin Transl Oncol
; 21(1): 94-105, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30627982
7.
Key points to optimizing management and research on cancer-associated thrombosis.
Clin Transl Oncol
; 20(2): 119-126, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28593335
8.
Nutritional support and parenteral nutrition in cancer patients: an expert consensus report.
Clin Transl Oncol
; 20(5): 619-629, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29043569
9.
Chronic opioid therapy in long-term cancer survivors.
Clin Transl Oncol
; 19(2): 236-250, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27443415
10.
Medical oncology future plan of the Spanish Society of Medical Oncology: challenges and future needs of the Spanish oncologists.
Clin Transl Oncol
; 19(4): 508-518, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28005259
11.
SEOM Clinical Guideline for bone metastases from solid tumours (2016).
Clin Transl Oncol
; 18(12): 1243-1253, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27896639
12.
SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2016).
Clin Transl Oncol
; 18(12): 1237-1242, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27896642
13.
Management of infection and febrile neutropenia in patients with solid cancer.
Clin Transl Oncol
; 18(6): 557-70, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26577106
14.
SEOM clinical guidelines in metastatic breast cancer 2015.
Clin Transl Oncol
; 17(12): 946-55, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26683474
15.
In vitro sequence-dependent synergistic effect of suramin and camptothecin.
Eur J Cancer
; 30A(11): 1670-4, 1994.
Artigo
em Inglês
| MEDLINE | ID: mdl-7833142
16.
Gemcitabine/vinorelbine in metastatic breast cancer patients previously treated with anthracyclines: results of a phase II trial.
Clin Breast Cancer
; 4(1): 46-50, 2003 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-12744758
17.
UFT in combination as adjuvant therapy for breast cancer. Grupo Oncologico de Sevilla Seville, Spain.
Oncology (Williston Park)
; 11(9 Suppl 10): 74-81, 1997 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-9348574
18.
SEOM clinical guidelines for the treatment of metastatic prostate cancer.
Clin Transl Oncol
; 16(12): 1060-6, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25319721
19.
Replied to "Some remarks to SEOM clinical guidelines on cardiovascular toxicity (2018)".
Clin Transl Oncol
; 21(12): 1788-1789, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31346971
20.
The oncology day hospital in Spain: an updated analysis of Spanish Society of Medical Oncology (SEOM) looking forward.
Clin Transl Oncol
; 19(3): 269-272, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28083756